A study to investigate incidence of relapses with fingolimod treatment in patients with relapsing-remitting multiple sclerosis, who had undergone prior treatment with Natalizumab.
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 03 Dec 2015 New trial record